TD Cowen analyst Ritu Baral reiterated a Buy rating on Opus Genetics (NASDAQ: IRD).The analyst commented: "High Conviction For Meaningful ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments